$106MSeries B, 19 November 2025
Funds expansion of its AI platform into therapeutics, agriculture and biomanufacturing.
- Amount
- $106M
- Stage
- Series B
- Announced
- 19 November 2025
- Lead
- Altimeter Capital
- Other investors
- Bezos Expeditions, Spark Capital, Insight Partners, Air Street Capital
- Use of funds
- Funds expansion of its AI platform into therapeutics, agriculture and biomanufacturing.
- Checked
- Announced by the company
- Sources
- Profluent Raises $106M to Scale Frontier AI Models for Programmable Biology - Business Wire businesswire.com
Profluent Raises $106M to Scale Frontier AI Models for Programmable Biology - Business Wire Business Wire